Back to Results
First PageMeta Content
Selective serotonin reuptake inhibitors / Organochlorides / Amines / Pfizer / Sertraline / Abnormal psychology / Premenstrual dysphoric disorder / Antidepressant / Placebo / Medicine / Psychiatry / Chemistry


[FDA Approved Labeling for Zoloft® for the Treatment of Social Anxiety Disorder Attachment to FDA Approval Letter for NDA[removed]S-045]
Add to Reading List

Document Date: 2004-01-13 09:43:19


Open Document

File Size: 106,00 KB

Share Result on Facebook

Company

I. Subgroup / /

Holiday

between day / /

IndustryTerm

chemical name / Treatment of Social Anxiety Disorder / treatment of panic disorder / treatment for major depressive disorder / food / treatment of major depressive disorder / /

MedicalCondition

Social Anxiety Disorder / panic attacks / major depressive disorder / obsessive-compulsive outpatients / secondary depressive disorder / Marks Fear Questionnaire Social Phobia Subscale / panic attack / panic disorder / agoraphobia / Late Luteal Phase Dysphoric Disorder / common disorder / additional placebo-controlled PTSD / social phobia / Premenstrual Dysphoric Disorder / INDICATIONS AND USAGE Major Depressive Disorder / chronic mild liver impairment / fatigue / Clinical Trials Major Depressive Disorder / full panic attacks / Renal Disease / chronic sertraline dosing / Illness / PTSD / Liver Disease / obsessive-compulsive disorder / psychomotor agitation / /

MedicalTreatment

oral contraceptives / hemodialysis / /

Organization

Patients and DOSAGE AND ADMINISTRATION / Yale / DOSAGE AND ADMINISTRATION / FDA / /

Person

Depressive Disorder / Panic Disorder / /

Position

investigator / Major / /

Product

polyethylene glycol / Zoloft / sertraline hydrochloride / SPS / /

PublishedMedium

the Daily Record / /

Technology

Pharmacokinetics / Pharmacodynamics / CGI / /

SocialTag